|
Parameter
|
SHC
|
Controls
|
|---|
| |
n (%)
|
(n%)
|
|---|
|
VPT < 4/8
|
654 (95.6)
|
457 (90.0)
|
|
CAN
|
289 (42.3)
|
n. d.
|
|
retinopathy
| | |
|
background
|
561 (82.0)
|
n. d.
|
|
proliferative
|
55 (8.0)
|
n. d.
|
|
Microalbuminuria
|
269 (39.2)
|
n. d.
|
|
creatinine >130μmol/l
|
104 (15.2)
|
71 (14.1)
|
|
prior amputation
|
249 (36.4)
| |
|
toe
|
152 (22.2)
|
n. d.
|
|
transmetatarsal
|
34 (5.0)
|
n. d.
|
|
below the knee
|
40 (5.8)
|
73 (14.4)
|
|
above the knee
|
23 (3.4)
|
53 (10.5)
|
|
CAD
|
567 (82.9)
|
396 (78.1)
|
|
prior AMI
|
47 (6.9)
|
41 (8.0)
|
|
prior stroke
|
51 (7.5)
|
48 (9.5)
|
|
hypertension
|
621 (90.8)
|
441 (87.0)
|
|
dyslipidemia
|
540 (78.9)
|
n. d.
|
|
smoking
|
231 (33.8)
|
158 (31.2)
|
- VPT vibration perception threshold.
- CAN cardiac anatomic neuropathy.
- CAD coronary artery disease.
- SHC structured health care group.
